Tendyne European Experience Registry

计划入组 400 人 · 首次发布于 2021 年 5 月 24 日

Expanded Clinical Study of the Tendyne Mitral Valve System

计划入组 191 人 · 首次发布于 2014 年 12 月 22 日

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

计划入组 103 人 · 首次发布于 2018 年 2 月 14 日

Tendon(ChitogenX)

Autologous non-bulbar dermal sheath derived fibroblast (Tendon injuries, RepliCel Life Sciences)

NEODYNE BIOSCIENCES, INC.

United States

Abbott's Tendyne System Receives FDA Approval as First Transcatheter Mitral Valve Replacement for Severe Calcification

FDA Approves Edwards' Sapien M3 as First Transseptal Mitral Valve Replacement System

TCT 2025 Unveils 28 Late-Breaking Cardiovascular Trials Featuring Novel Drug-Eluting Technologies and AI-Enabled Diagnostics